REBECCA COWART: Open Payments
NPI 1457776189 · SUWANEE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$457 in 24 payments from 15 companies in 2025. Trend: 2023 $437 · 2024 $979 · 2025 $457
Food & beverage: $457
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $65 |
| Novo Nordisk Inc | 3 | $61 |
| Lilly USA, LLC | 3 | $59 |
| PFIZER INC. | 2 | $48 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| Axsome Therapeutics, Inc. | 2 | $33 |
| Exact Sciences Corporation | 1 | $21 |
| Acella Pharmaceuticals, LLC | 1 | $19 |
| Echosens North America, Inc. | 1 | $19 |
| Dexcom, Inc. | 1 | $18 |
Products named: Veozah, ZEPBOUND, Ozempic, Auvelity, PREVNAR 20, NURTEC ODT, Cologuard Collection Kit, Wegovy.
Industry payments across GA — which companies pay providers there.
